Mizuho Financial Group, Inc. American Depositary Shares (Each representing one-fifth of an Ordinary Share)
MFGDividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| June 18, 2026 | $0.09 | 2026-03-31 | 2026-03-31 |
| December 15, 2025 | $0.09 | 2025-09-30 | 2025-09-30 |
| June 16, 2025 | $0.10 | 2025-03-31 | 2025-03-31 |
| December 16, 2024 | $0.09 | 2024-09-30 | 2024-09-30 |
| June 17, 2024 | $0.07 | 2024-03-27 | 2024-03-28 |
Dividends Summary
- Consistent Payer: Mizuho Financial Group, Inc. American Depositary Shares (Each representing one-fifth of an Ordinary Share) has rewarded shareholders with 23 dividend payments over the past 15 years.
- Total Returned Value: Investors who held MFG shares during this period received a total of $1.66 per share in dividend income.
- Latest Payout: The most recent dividend of $0.09/share was paid 30 days ago, on June 18, 2026.
- Dividend Growth: Since 2011, the dividend payout has grown by 17.2%, from $0.08 to $0.09.
Company News
SanDisk stock has surged 4,000% in 12 months and 600% year-to-date, trading near $1,650 with record highs. The bull case centers on strong AI-driven demand for memory and storage, with $42 billion in locked supply agreements and analyst price targets ranging from $2,300 to $3,250. However, short interest has simultaneously hit record levels, sugg...
Qualcomm shares have plummeted 17% over seven consecutive trading sessions, erasing all 2025 gains and returning to 2020 price levels. While broader geopolitical tensions and tech sector flight contributed to the decline, the stock's technical damage is significant with a broken uptrend. However, the RSI is extremely oversold without company-spec...
Mizuho USA Foundation announced $1 million in 2025 grants focused on strengthening communities and supporting young adults in technology skills training and employment opportunities. The foundation awarded a $450,000 three-year FutureReady Grant to Pursuit for an AI training initiative, $275,000 in Opportunity Grants to eleven nonprofits, and $25...
Immix Biopharma priced an underwritten offering of common stock and pre-funded warrants, expecting to raise $100 million to fund NXC-201 development and corporate operations through mid-2027.
Tesla shows signs of recovery in December with technical strength, positive analyst sentiment, and improving operational performance, particularly in China's EV market, despite challenges in European sales.
